Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The putative role of ferroptosis in gastric cancer: a review. | Eur J Cancer Prev | 2023 | 37318883 | PubTator, text mining | PubMed |
| Assessing Autism in Deaf/Hard-of-Hearing Youths: Interdisciplinary Teams, COVID Considerations, and Future Directions. | Perspect Psychol Sci | 2023 | 37314896 | PubTator, text mining | PubMed |
| Cell-based and cell-free immunotherapies for glioblastoma: current status and future directions. | Front Immunol | 2023 | 37304305 | PubTator, text mining | PubMed |
| Cytokine release syndrome and cancer immunotherapies - historical challenges and promising futures. | Front Immunol | 2023 | 37304291 | PubTator, text mining | PubMed |
| Advances in Immunotherapeutic Approaches to Type 1 Diabetes. | Int J Mol Sci | 2023 | 37298175 | PubTator, text mining | PubMed |
| Strategies for Reducing Toxicity and Enhancing Efficacy of Chimeric Antigen Receptor T Cell Therapy in Hematological Malignancies. | Int J Mol Sci | 2023 | 37298069 | PubTator, text mining | PubMed |
| Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy. | Cancers (Basel) | 2023 | 37296972 | PubTator, text mining | PubMed |
| CAR-T Cells Immunotherapies for the Treatment of Acute Myeloid Leukemia-Recent Advances. | Cancers (Basel) | 2023 | 37296906 | PubTator, text mining | PubMed |
| Combination of High-Resolution Structures for the B Cell Receptor and Co-Receptors Provides an Understanding of Their Interactions with Therapeutic Antibodies. | Cancers (Basel) | 2023 | 37296844 | PubTator, text mining | PubMed |
| Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR. | Nat Biomed Eng | 2023 | 37291434 | PubTator, text mining | PubMed |
| ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma. | Nat Commun | 2023 | 37291203 | PubTator, text mining | PubMed |
| Biomaterial-based gene therapy. | MedComm (2020) | 2023 | 37284583 | PubTator, text mining | PubMed |
| Umbilical cord blood derived cellular therapy: advances in clinical development. | Front Oncol | 2023 | 37274288 | PubTator, text mining | PubMed |
| Understanding CAR T cell therapy and its role in ovarian cancer and peritoneal carcinomatosis from ovarian cancer. | Front Oncol | 2023 | 37274261 | PubTator, text mining | PubMed |
| Deciphering immune microenvironment and cell evasion mechanisms in human gliomas. | Front Oncol | 2023 | 37274252 | PubTator, text mining | PubMed |
| Regeneration of T cells from human-induced pluripotent stem cells for CAR-T cell medicated immunotherapy. | Front Bioeng Biotechnol | 2023 | 37274170 | PubTator, text mining | PubMed |
| T cells with split CARs specific for NKG2D ligands and PD-L1 exhibit improved selectivity towards monocyte-derived cells while effective in eliminating acute myeloid leukaemia in vivo. | J Cancer Res Clin Oncol | 2023 | 37270461 | PubTator, text mining | PubMed |
| Efficient chimeric antigen receptor targeting of a central epitope of CD22. | J Biol Chem | 2023 | 37269947 | PubTator, text mining | PubMed |
| Impact of serum‑free media on the expansion and functionality of CD19.CAR T‑cells. | Int J Mol Med | 2023 | 37264971 | PubTator, text mining | PubMed |
| Release Assays and Potency Assays for CAR T-Cell Interventions. | Adv Exp Med Biol | 2023 | 37258787 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=29